Sale!

CRX Gene Cone-Rod Dystrophy Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CRX Gene Cone-Rod Dystrophy Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CRX gene, which are linked to Cone-Rod Dystrophy Type 2, a rare genetic disorder. This condition affects the retina and leads to the progressive loss of vision, starting with color vision and night vision difficulties, eventually progressing to a loss of peripheral and central vision. Early detection through this genetic test can be crucial for managing the condition and exploring potential treatment options. The test is priced at 4400 AED and involves a comprehensive analysis of the CRX gene to pinpoint any genetic abnormalities. By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic makeup, enabling them to take proactive steps towards managing their ocular health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CRX Gene Cone-rod dystrophy type 2 Genetic Test

At DNA Labs UAE, we offer the CRX Gene Cone-rod dystrophy type 2 Genetic Test for individuals who suspect they may have this rare genetic disorder affecting the retina of the eye. This comprehensive NGS (next-generation sequencing) genetic test detects mutations in the CRX gene responsible for cone-rod dystrophy type 2.

Test Details

The CRX gene is associated with cone-rod dystrophy type 2, a rare genetic disorder that affects the retina of the eye. NGS genetic testing involves sequencing the entire CRX gene to identify any variations or mutations present. This type of testing is more comprehensive than traditional methods, which may only look for specific mutations or variations.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ophthalmology Disorders
  • Doctor: Ophthalmologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CRX Gene Cone-rod dystrophy type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by CRX Gene Cone-rod dystrophy type 2.

Importance of Genetic Testing

NGS testing can help diagnose cone-rod dystrophy type 2 and provide valuable information about the genetic cause of the condition. This information can be used to develop personalized treatment plans and assist individuals and their families in understanding their risk of passing the condition on to future generations.

It is crucial to note that genetic testing should always be done in consultation with a healthcare provider or genetic counselor. These professionals can help interpret the test results and provide guidance on the next steps to take.

Test Name CRX Gene Cone-rod dystrophy type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CRX Gene Cone-rod dystrophy type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CRX Gene Cone-rod dystrophy type 2 NGS Genetic DNA Test gene CRX
Test Details

The CRX gene is associated with cone-rod dystrophy type 2, a rare genetic disorder that affects the retina of the eye. NGS (next-generation sequencing) genetic testing can be used to detect mutations in the CRX gene that are responsible for this condition.

NGS testing involves sequencing the entire CRX gene to identify any variations or mutations that may be present. This type of testing is more comprehensive than traditional genetic testing methods, which may only look for specific mutations or variations.

NGS testing can help diagnose cone-rod dystrophy type 2 and provide information about the genetic cause of the condition. This information can be used to develop personalized treatment plans and to help individuals and their families understand their risk of passing the condition on to future generations.

It is important to note that genetic testing should be done in consultation with a healthcare provider or genetic counselor, who can help interpret the results and provide guidance on next steps.